Apple Health Drug Coverage Criteria
Clinical policies effective December 1, 2020, are now available on the Apple Health (Medicaid) Drug Coverage Criteria webpage.
- Endocrine and Metabolic Agents: Metabolic Modifiers - elapegademase-lvlr
- Endocrine and Metabolic Agents: Metabolic Modifiers - X-Linked Hypophosphatemia (XLH) Agents - burosumab-twza
- Oncology: Radiopharmaceuticals – lutetium Lu 177 dotatate
- Opthalmics: Gene Therapy – voretigene neparvovec-rzyl
These policies outline coverage and authorization criteria used by the Apple Health (Medicaid) pharmacy program.
Please email questions to AppleHealthPharmacyPolicy@hca.wa.gov
|